CD44‐Specific A6 Short Peptide Boosts Targetability and Anticancer Efficacy of Polymersomal Epirubicin to Orthotopic Human Multiple Myeloma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD44‐Specific A6 Short Peptide Boosts Targetability and Anticancer Efficacy of Polymersomal Epirubicin to Orthotopic Human Multiple Myeloma
Authors
Keywords
-
Journal
ADVANCED MATERIALS
Volume -, Issue -, Pages 1904742
Publisher
Wiley
Online
2019-09-27
DOI
10.1002/adma.201904742
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical cancer nanomedicine
- (2019) Joy Wolfram et al. Nano Today
- Protein Toxin Chaperoned by LRP-1-Targeted Virus-Mimicking Vesicles Induces High-Efficiency Glioblastoma Therapy In Vivo
- (2018) Yu Jiang et al. ADVANCED MATERIALS
- Investigational agents in immunotherapy: a new horizon for the treatment of multiple myeloma
- (2018) Cindy Varga et al. BRITISH JOURNAL OF HAEMATOLOGY
- Current use of monoclonal antibodies in the treatment of multiple myeloma
- (2018) Cindy Varga et al. BRITISH JOURNAL OF HAEMATOLOGY
- Current developments in immunotherapy in the treatment of multiple myeloma
- (2018) Martin Köhler et al. CANCER
- Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma
- (2018) Pilar de la Puente et al. JOURNAL OF CONTROLLED RELEASE
- Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model
- (2018) Walhan Alshaer et al. JOURNAL OF CONTROLLED RELEASE
- GE11-Directed Functional Polymersomal Doxorubicin as an Advanced Alternative to Clinical Liposomal Formulation for Ovarian Cancer Treatment
- (2018) Yan Zou et al. MOLECULAR PHARMACEUTICS
- Advancements in Nanomedicine for Multiple Myeloma
- (2018) Alexandre Detappe et al. TRENDS IN MOLECULAR MEDICINE
- Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma
- (2018) S. Manier et al. Nature Communications
- Peptide density targets and impedes triple negative breast cancer metastasis
- (2018) Daxing Liu et al. Nature Communications
- Progress and challenges towards targeted delivery of cancer therapeutics
- (2018) Daniel Rosenblum et al. Nature Communications
- Pathogenesis of bone disease in multiple myeloma: from bench to bedside
- (2018) Evangelos Terpos et al. Blood Cancer Journal
- Global Burden of Multiple Myeloma
- (2018) Andrew J. Cowan et al. JAMA Oncology
- Nanomedicines for the treatment of hematological malignancies
- (2018) Anil K. Deshantri et al. JOURNAL OF CONTROLLED RELEASE
- Predicting treatment benefit in multiple myeloma through simulation of alternative treatment effects
- (2018) Joske Ubels et al. Nature Communications
- Peptide-decorated polymeric nanomedicines for precision cancer therapy
- (2018) Huanli Sun et al. JOURNAL OF CONTROLLED RELEASE
- Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma
- (2018) Meletios A. Dimopoulos et al. NEW ENGLAND JOURNAL OF MEDICINE
- The activated conformation of integrin β7 is a novel multiple myeloma–specific target for CAR T cell therapy
- (2017) Naoki Hosen et al. NATURE MEDICINE
- Multiple myeloma
- (2017) Shaji K. Kumar et al. Nature Reviews Disease Primers
- Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus
- (2016) Quanyin Hu et al. ADVANCED MATERIALS
- Robust, tumor-homing and redox-sensitive polymersomal doxorubicin: A superior alternative to Doxil and Caelyx?
- (2016) Yan Zou et al. JOURNAL OF CONTROLLED RELEASE
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Clinical Translation of Nanomedicine
- (2015) Yuanzeng Min et al. CHEMICAL REVIEWS
- CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients
- (2015) F. Birzele et al. CLINICAL CANCER RESEARCH
- Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin
- (2015) Leila Arabi et al. JOURNAL OF CONTROLLED RELEASE
- Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts
- (2015) Yinan Zhong et al. JOURNAL OF CONTROLLED RELEASE
- An Anti-B Cell Maturation Antigen Bispecific Antibody for Multiple Myeloma
- (2015) Nitya S. Ramadoss et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The Cyclophilin A–CD147 complex promotes the proliferation and homing of multiple myeloma cells
- (2015) Di Zhu et al. NATURE MEDICINE
- Modulation of CD44 Activity by A6-Peptide
- (2015) Malcolm Finlayson Frontiers in Immunology
- Liposomal carfilzomib nanoparticles effectively target multiple myeloma cells and demonstrate enhanced efficacy in vivo
- (2014) Jonathan D. Ashley et al. JOURNAL OF CONTROLLED RELEASE
- Engineered nanomedicine for myeloma and bone microenvironment targeting
- (2014) A. Swami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Systematic Analysis of Peptide Linker Length and Liposomal Polyethylene Glycol Coating on Cellular Uptake of Peptide-Targeted Liposomes
- (2013) Jared F. Stefanick et al. ACS Nano
- CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma
- (2013) M. Casucci et al. BLOOD
- Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications
- (2013) C C Bjorklund et al. LEUKEMIA
- Advances in the Biology and Treatment of Bone Disease in Multiple Myeloma
- (2011) Noopur Raje et al. CLINICAL CANCER RESEARCH
- A6 Peptide Activates CD44 Adhesive Activity, Induces FAK and MEK Phosphorylation, and Inhibits the Migration and Metastasis of CD44-Expressing Cells
- (2011) R. S. Piotrowicz et al. MOLECULAR CANCER THERAPEUTICS
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correlation of High-Resolution X-Ray Micro-Computed Tomography with Bioluminescence Imaging of Multiple Myeloma Growth in a Xenograft Mouse Model
- (2009) Andrei A. Postnov et al. CALCIFIED TISSUE INTERNATIONAL
- A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous Å6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer
- (2008) Sharad A. Ghamande et al. GYNECOLOGIC ONCOLOGY
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started